Altered gut microbiota profile in patients with generalized anxiety disorder

Journal of Psychiatric Research

Volumn 104, Issue , 2018, Pages 130-136

  Jiang, Hai yin ^a   Zhang, Xue ^a   Yu, Zheng he ^b   Zhang, Zhe ^c   Deng, Min ^a   Zhao, Jian hua ^d   Ruan, Bing ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b HANGZHOU SEVENTH PEOPLE S HOSPITAL   (China)

^c ZHEJIANG UNIVERSITY   (China)

^d Shanghai Majorbio Bio pharm Technology Co Ltd   (China)

Author keywords

[No Author keywords available]

Indexed keywords

SHORT CHAIN FATTY ACID;

ADULT; ANXIETY DISORDER; ARTICLE; BACTEROIDETES; BODY MASS; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DSM-IV; DYSBIOSIS; ESCHERICHIA; EUBACTERIUM; EUBACTERIUM RECTALE; FEMALE; FUSOBACTERIUM; GENERALIZED ANXIETY DISORDER; HAMILTON ANXIETY SCALE; HUMAN; INTESTINE FLORA; LACHNOSPIRA; MALE; METAGENOMICS; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; PYROSEQUENCING; REMISSION; RUMINOCOCCUS; RUMINOCOCCUS GNAVUS; SHIGELLA; CASE CONTROL STUDY; COHORT ANALYSIS; FECES; GASTROINTESTINAL TRACT; GENETICS; METABOLISM; MICROBIOLOGY; NONPARAMETRIC TEST; PATHOLOGY;

ADULT; ANXIETY DISORDERS; CASE-CONTROL STUDIES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DYSBIOSIS; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; MALE; STATISTICS, NONPARAMETRIC;

EID: 85049963113     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2018.07.007     Document Type: Article

References (27)

1. Ballenger, J.C., Davidson, J.R., Lecrubier, Y., Nutt, D.J., Borkovec, T.D., Rickels, K., Stein, D.J., Wittchen, H.U., Consensus statement on generalized anxiety disorder from the international consensus group on depression and anxiety. J. Clin. Psychiatr. 62:11 (2001), 53–58.
2. Cattaneo, A., Cattane, N., Galluzzi, S., Provasi, S., Lopizzo, N., Festari, C., Ferrari, C., Guerra, U.P., Paghera, B., Muscio, C., Bianchetti, A., Volta, G.D., Turla, M., Cotelli, M.S., Gennuso, M., Prelle, A., Zanetti, O., Lussignoli, G., Mirabile, D., Bellandi, D., Gentile, S., Belotti, G., Villani, D., Harach, T., Bolmont, T., Padovani, A., Boccardi, M., Frisoni, G.B., Group, I.-F., Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol. Aging 49 (2017), 60–68.
3. Cryan, J.F., Dinan, T.G., Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nature reviews. Neuroscience 13:10 (2012), 701–712.
4. Dethlefsen, L., Eckburg, P.B., Bik, E.M., Relman, D.A., Assembly of the human intestinal microbiota. Trends Ecol. Evol. 21:9 (2006), 517–523.
5. Evans, S.J., Bassis, C.M., Hein, R., Assari, S., Flowers, S.A., Kelly, M.B., Young, V.B., Ellingrod, V.E., McInnis, M.G., The gut microbiome composition associates with bipolar disorder and illness severity. J. Psychiatr. Res. 87 (2017), 23–29.
6. First, M.B., Spitzer, R., Gibbon, M., Williams, J.B.W., Structured Clinical Interview for DSM-iv Axis I Disorders, Clinician Version (SCID-cv). 1996, American Psychiatric Publishing, Washington, DC.
7. Flowers, S.A., Evans, S.J., Ward, K.M., McInnis, M.G., Ellingrod, V.L., Interaction between atypical antipsychotics and the gut microbiome in a bipolar disease cohort. Pharmacotherapy 37:3 (2017), 261–267.
8. Foster, J.A., McVey Neufeld, K.A., Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 36:5 (2013), 305–312.
9. Goehler, L.E., Park, S.M., Opitz, N., Lyte, M., Gaykema, R.P., Campylobacter jejuni infection increases anxiety-like behavior in the holeboard: possible anatomical substrates for viscerosensory modulation of exploratory behavior. Brain Behav. Immun. 22:3 (2008), 354–366.
10. Hamilton, M., The assessment of anxiety states by rating. Br. J. Med. Psychol. 32:1 (1959), 50–55.
11. Hettema, J.M., Neale, M.C., Kendler, K.S., A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am. J. Psychiatr. 158:10 (2001), 1568–1578.
12. Hoge, E.A., Ivkovic, A., Fricchione, G.L., Generalized anxiety disorder: diagnosis and treatment. Br. Med. J., 345, 2012, e7500.
13. Jiang, H., Ling, Z., Zhang, Y., Mao, H., Ma, Z., Yin, Y., Wang, W., Tang, W., Tan, Z., Shi, J., Li, L., Ruan, B., Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav. Immun. 48 (2015), 186–194.
14. Kessler, R.C., Berglund, P., Demler, O., Jin, R., Merikangas, K.R., Walters, E.E., Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch. Gen. Psychiatr. 62:6 (2005), 593–602.
15. Lyte, M., Li, W., Opitz, N., Gaykema, R.P., Goehler, L.E., Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium. Physiol. Behav. 89:3 (2006), 350–357.
16. Macedo, D., Filho, A., Soares de Sousa, C.N., Quevedo, J., Barichello, T., Junior, H.V.N., Freitas de Lucena, D., Antidepressants, antimicrobials or both? Gut microbiota dysbiosis in depression and possible implications of the antimicrobial effects of antidepressant drugs for antidepressant effectiveness. J. Affect. Disord. 208 (2017), 22–32.
17. Maes, M., Mihaylova, I., Leunis, J.C., Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut-intestinal permeability. J. Affect. Disord. 99:1–3 (2007), 237–240.
18. McMurdie, P.J., Holmes, S., phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One, 8(4), 2013, e61217.
19. Ohkusa, T., Okayasu, I., Ogihara, T., Morita, K., Ogawa, M., Sato, N., Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis. Gut 52:1 (2003), 79–83.
20. Ormel, J., VonKorff, M., Ustun, T.B., Pini, S., Korten, A., Oldehinkel, T., Common mental disorders and disability across cultures. Results from the WHO collaborative study on psychological problems in general health care. Jama 272:22 (1994), 1741–1748.
21. Roberts, G.L., Fusobacterial infections: an underestimated threat. Br. J. Biomed. Sci. 57:2 (2000), 156–162.
22. Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W.S., Huttenhower, C., Metagenomic biomarker discovery and explanation. Genome Biol., 12(6), 2011, R60.
23. Sheehan, D.V., Lecrubier, Y., Sheehan, K.H., Amorim, P., Janavs, J., Weiller, E., Hergueta, T., Baker, R., Dunbar, G.C., The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatr. 59:20 (1998), 22–33 quiz 34–57.
24. Stevens, B.R., Goel, R., Seungbum, K., Richards, E.M., Holbert, R.C., Pepine, C.J., Raizada, M.K., Increased human intestinal barrier permeability plasma biomarkers zonulin and FABP2 correlated with plasma LPS and altered gut microbiome in anxiety or depression. Gut 8 (2018), 1555–1557.
25. Stilling, R.M., van de Wouw, M., Clarke, G., Stanton, C., Dinan, T.G., Cryan, J.F., The neuropharmacology of butyrate: the bread and butter of the microbiota-gut-brain axis?. Neurochem. Int. 99 (2016), 110–132.
26. Wang, Y., Kasper, L.H., The role of microbiome in central nervous system disorders. Brain Behav. Immun. 38 (2014), 1–12.
27. Zhernakova, A., Kurilshikov, A., Bonder, M.J., Tigchelaar, E.F., Schirmer, M., Vatanen, T., Mujagic, Z., Vila, A.V., Falony, G., Vieira-Silva, S., Wang, J., Imhann, F., Brandsma, E., Jankipersadsing, S.A., Joossens, M., Cenit, M.C., Deelen, P., Swertz, M.A., LifeLines cohort, S., Weersma, R.K., Feskens, E.J., Netea, M.G., Gevers, D., Jonkers, D., Franke, L., Aulchenko, Y.S., Huttenhower, C., Raes, J., Hofker, M.H., Xavier, R.J., Wijmenga, C., Fu, J., Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352:6285 (2016), 565–569.